Recent Publications by DanioLabs Ltd: |
Non-associative learning in larval zebrafish.
Habituation, where a response is reduced when exposed to a continuous... | 2nd August, 2008
| DanioLabs Ltd (a wholly owned subsidiary of VASTox plc), Unit 7330,
| Neuropsychopharmacology. 2008 Apr;33(5):1206-15. Epub 2007 Jun 20.
DOI Direct Link |
GBR12909 possesses anticonvulsant activity in zebrafish and rodent models of generalized epilepsy but cardiac ion channel effects limit its clinical utility.
BACKGROUND/AIMS: GBR12909 has been reported to possess anticonvulsant... | 6th December, 2007
| DanioLabs
| Pharmacology. 2007;79(4):250-8. Epub 2007 Apr 27.
DOI Direct Link |
Zebrafish offer the potential for a primary screen to identify a wide variety of potential anticonvulsants.
The search for novel anticonvulsants requires appropriate model systems in... | 19th August, 2007
| DanioLabs Ltd., 7330 Cambridge Research Park, Cambridge CB25 9TN, UK.
| Epilepsy Res. 2007 Jun;75(1):18-28. Epub 2007 May 7.
DOI Direct Link |
A rapid, high content, in vivo model of glucocorticoid-induced osteoporosis.
Glucocorticoid-induced osteoporosis (GIOP) is a major clinical problem... | 9th December, 2006
| DanioLabs Ltd, Cambridge, UK.
| Biotechnol J. 2006 Jun;1(6):651-5.
DOI Direct Link |
High-throughput in vivo screening for bone anabolic compounds with zebrafish.
Osteoporosis and diseases of bone loss are a major public health problem... | 19th May, 2006
| DanioLabs
| J Biomol Screen. 2005 Dec;10(8):823-31. Epub 2005 Oct 18.
DOI Direct Link |
Zebrafish as a pharmacological tool: the how, why and when.
Zebrafish combine the relevance of a vertebrate with the scalability of an... | 1st April, 2005
| DanioLabs Ltd, 7330 Cambridge Research Park, Cambridge CB5 9TN, UK.
| Curr Opin Pharmacol. 2004 Oct;4(5):504-12.
DOI Direct Link |
